Johnson & Johnson - 54 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of March 01, 2024 is 162.12.
  • The all-time high Johnson & Johnson stock closing price was 175.78 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 175.97, which is 8.5% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 144.95, which is 10.6% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 159.31.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 158.6693 158.7632 162.1200 154.5651 162.1200 4.22%
2023 156.6266 171.6849 173.6697 143.3636 155.5575 -8.60%
2022 164.0480 161.0573 175.7763 149.4396 170.2011 5.97%
2021 153.3778 143.3111 166.3986 141.0448 160.6160 11.45%
2020 131.6754 130.0982 144.1169 99.7003 144.1169 10.85%
2019 119.0943 111.5706 130.5171 109.7977 130.0091 15.35%
2018 114.5847 118.3910 129.1162 102.9318 112.7060 -5.14%
2017 108.9514 96.0233 121.5032 92.6412 118.8077 24.40%
2016 92.9055 81.0063 102.5478 77.1931 95.5010 15.32%
2015 79.2140 81.8251 84.8519 72.6145 82.8122 1.16%
2014 77.8809 69.3429 84.9566 65.9836 81.8642 17.34%
2013 64.3959 52.3760 72.8470 52.3021 69.7695 34.62%
2012 48.5964 46.9799 53.1520 44.8754 51.8289 10.83%
2011 44.4852 43.2239 47.5664 40.0327 46.7660 9.89%
2010 41.9839 42.9851 44.2193 38.5348 42.5565 -0.58%
2009 37.7960 38.9952 43.1712 30.2139 42.8057 11.28%
2008 41.1210 41.2142 46.0710 35.5747 38.4680 -7.77%
2007 39.4845 40.4867 42.7712 36.7982 41.7081 3.61%
2006 37.4856 36.7113 41.8944 33.8342 40.2550 12.44%
2005 38.1405 36.7400 40.7101 35.7641 35.7999 -3.36%
2004 32.3445 29.5955 37.2423 28.4827 37.0437 25.17%
2003 29.8628 31.1467 33.1589 27.7890 29.5955 -2.11%
2002 32.2187 32.5985 36.4835 23.3918 30.2348 -7.88%
2001 28.6635 27.9484 33.8591 22.8883 32.8207 13.97%
2000 24.3445 24.9646 28.7978 18.6165 28.7978 14.04%
1999 25.3282 22.1354 28.7313 20.6122 25.2516 12.46%
1998 19.9632 17.1914 23.8245 16.9113 22.4539 28.99%
1997 15.6568 12.9612 17.6881 12.9612 17.4080 34.31%
1996 12.5506 10.8134 14.0033 10.8134 12.9612 18.11%
1995 8.7631 6.8641 11.7440 6.7696 10.9739 59.14%
1994 5.7576 5.5622 7.0064 4.5456 6.8956 25.00%
1993 5.0994 5.9378 5.9378 4.3533 5.5167 -8.93%
1992 5.8672 6.6124 6.8556 5.1255 6.0578 -10.19%
1991 5.2390 4.0534 6.8038 3.7998 6.7449 62.34%
1990 3.6038 3.3957 4.2065 2.9488 4.1547 23.38%
1989 2.8093 2.3192 3.3673 2.3192 3.3673 42.63%
1988 2.2182 2.1138 2.4290 1.9039 2.3608 16.52%
1987 2.3155 1.7967 2.8157 1.7359 2.0261 15.79%
1986 1.6823 1.3539 1.9599 1.2461 1.7498 27.42%
1985 1.1471 0.9037 1.4288 0.8910 1.3732 49.85%
1984 0.8542 1.0019 1.0386 0.7040 0.9164 -8.53%
1983 1.1055 1.1850 1.2247 0.9619 1.0019 -15.66%
1982 0.9669 0.8558 1.2209 0.7640 1.1879 36.93%
1981 0.7880 0.7583 0.8876 0.6618 0.8675 14.54%
1980 0.5947 0.5668 0.7593 0.4945 0.7574 29.43%
1979 0.5251 0.5333 0.5908 0.4748 0.5852 10.48%
1978 0.5456 0.5269 0.6338 0.4657 0.5297 -1.76%
1977 0.4895 0.5378 0.5392 0.4334 0.5392 0.43%
1976 0.5907 0.6129 0.6546 0.4956 0.5369 -12.04%
1975 0.6023 0.5592 0.6702 0.4969 0.6104 12.02%
1974 0.6611 0.7471 0.7971 0.5049 0.5449 -27.70%
1973 0.7929 0.8552 0.8685 0.6986 0.7537 -13.22%
1972 0.7836 0.6481 0.8786 0.6290 0.8685 32.98%
1971 0.5631 0.3776 0.6556 0.3776 0.6531 73.74%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $388.727B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $716.120B 119.25
Novo Nordisk (NVO) Denmark $537.472B 44.28
Merck (MRK) United States $322.026B 84.77
AbbVie (ABBV) United States $310.988B 15.85
Novartis AG (NVS) Switzerland $214.016B 14.83
AstraZeneca (AZN) United Kingdom $198.920B 17.63
Pfizer (PFE) United States $149.978B 14.51
Sanofi (SNY) $121.041B 10.90
Innoviva (INVA) United States $0.979B 6.82